Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Timothy Sondej"'
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 31:857-861
Objectives Intravesical bacillus Calmette-Guerin (BCG) immunotherapy is a standard treatment for high-grade non-muscle-invasive bladder cancer (NMIBC). We evaluated outcomes of BCG therapy for NMIBC in patients with a previous history of prostate can
Autor:
Marcus L. Quek, Robert C. Flanigan, Timothy Sondej, Manoj V. Rao, Cory M. Hugen, Gary D. Steinberg, Chandy Ellimoottil, Gautam Jayram
Publikováno v:
ISRN Urology
Purpose. Intravesical Bacillus Calmette-Guerin (BCG) immunotherapy is indicated for high-grade nonmuscle-invasive bladder cancer (NMIBC). The efficacy of BCG in patients with a history of previous pelvic radiotherapy (RT) may be diminished. We evalua